TCBPW Income Quality from 2010 to 2025

TCBPW Stock  USD 0.02  0  6.75%   
TC BioPharm Income Quality yearly trend continues to be fairly stable with very little volatility. Income Quality is likely to outpace its year average in 2025. Income Quality is an assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure. View All Fundamentals
 
Income Quality  
First Reported
2010-12-31
Previous Quarter
1.61
Current Value
2.5
Quarterly Volatility
2.65090819
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TC BioPharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TC BioPharm's main balance sheet or income statement drivers, such as Interest Income of 1.9 K, Depreciation And Amortization of 638 K or Interest Expense of 90.7 K, as well as many indicators such as Price To Sales Ratio of 0.5, Dividend Yield of 0.0 or PTB Ratio of 0.22. TCBPW financial statements analysis is a perfect complement when working with TC BioPharm Valuation or Volatility modules.
  
Check out the analysis of TC BioPharm Correlation against competitors.

Latest TC BioPharm's Income Quality Growth Pattern

Below is the plot of the Income Quality of TC BioPharm plc over the last few years. It is an assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure. TC BioPharm's Income Quality historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TC BioPharm's overall financial position and show how it may be relating to other accounts over time.
Income Quality10 Years Trend
Slightly volatile
   Income Quality   
       Timeline  

TCBPW Income Quality Regression Statistics

Arithmetic Mean1.85
Geometric Mean1.29
Coefficient Of Variation142.97
Mean Deviation1.30
Median1.11
Standard Deviation2.65
Sample Variance7.03
Range11.2304
R-Value0.32
Mean Square Error6.74
R-Squared0.10
Significance0.22
Slope0.18
Total Sum of Squares105.41

TCBPW Income Quality History

2025 2.5
2024 1.61
2023 1.79
2022 11.64
2021 0.41
2020 0.63

About TC BioPharm Financial Statements

TC BioPharm investors use historical fundamental indicators, such as TC BioPharm's Income Quality, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TC BioPharm. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Quality 1.61  2.50 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.